Norris Medicines Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

5.64

8.36

9.44

12.25

7.84

Operating profit

-0.18

0.92

-0.07

-1.74

-2.16

Interest

0.37

1.50

1.48

1.63

0.88

Gross profit

-0.53

-0.56

-1.53

-3.33

-2.95

EPS (Rs)

-1.20

-1.76

-3.29

-5.00

-2.86

Other income

0.03

0.01

0.03

0.05

0.09

Stock adjustment

-0.50

0.13

2.04

-0.79

-0.64

Raw material

3.16

3.23

3.57

9.53

5.16

Power and fuel

-

-

-

-

-

Employee expenses

1.82

2.30

2.33

3.10

3.23

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1.34

1.77

1.57

2.15

2.25

Provisions made

-

-

-

-

-

Depreciation

0.57

0.63

0.66

0.67

0.73

Taxation

0.09

0.56

1.08

0.97

-0.84

Net profit / loss

-1.19

-1.75

-3.26

-4.96

-2.84

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

9.93

9.93

9.93

9.93

9.93

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-3.28

11.04

-0.76

-14.21

-27.48

GPM (%)

-9.29

-6.73

-16.14

-27.04

-37.23

NPM (%)

-20.95

-20.89

-34.48

-40.34

-35.83